59 related articles for article (PubMed ID: 9886377)
1. IL-12 is an effective adjuvant for induction of mucosal immunity.
Boyaka PN; Marinaro M; Jackson RJ; Menon S; Kiyono H; Jirillo E; McGhee JR
J Immunol; 1999 Jan; 162(1):122-8. PubMed ID: 9886377
[TBL] [Abstract][Full Text] [Related]
2. Mucosally induced immunoglobulin E-associated inflammation in the respiratory tract.
Simecka JW; Jackson RJ; Kiyono H; McGhee JR
Infect Immun; 2000 Feb; 68(2):672-9. PubMed ID: 10639432
[TBL] [Abstract][Full Text] [Related]
3. Subcutaneous injection of interleukin 12 induces systemic inflammatory responses in humans: implications for the use of IL-12 as vaccine adjuvant.
Portielje JE; Kruit WH; Eerenberg AJ; Schuler M; Sparreboom A; Lamers CH; Gratama JW; Stoter G; Huber C; Hack CE
Cancer Immunol Immunother; 2005 Jan; 54(1):37-43. PubMed ID: 15693137
[TBL] [Abstract][Full Text] [Related]
4. Promising Cytokine Adjuvants for Enhancing Tuberculosis Vaccine Immunity.
Cao X; Fu YX; Peng H
Vaccines (Basel); 2024 Apr; 12(5):. PubMed ID: 38793728
[TBL] [Abstract][Full Text] [Related]
5. Immunoinformatics Approach to Design a Chimeric CD70-Peptide Vaccine against Renal Cell Carcinoma.
Namdari H; Rezaei F; Heidarnejad F; Yaghoubzad-Maleki M; Karamigolbaghi M
J Immunol Res; 2024; 2024():2875635. PubMed ID: 38314087
[TBL] [Abstract][Full Text] [Related]
6. Role of Interleukin-6 in the Antigen-Specific Mucosal Immunoglobulin A Responses Induced by CpG Oligodeoxynucleotide-Loaded Cationic Liposomes.
Tada R; Honjo E; Muto S; Takayama N; Kiyono H; Kunisawa J; Negishi Y
Membranes (Basel); 2022 Jun; 12(6):. PubMed ID: 35736342
[TBL] [Abstract][Full Text] [Related]
7. Role of interleukin-6 in antigen-specific mucosal immunoglobulin A induction by cationic liposomes.
Tada R; Hidaka A; Tanazawa Y; Ohmi A; Muto S; Ogasawara M; Saito M; Ohshima A; Iwase N; Honjo E; Kiyono H; Kunisawa J; Negishi Y
Int Immunopharmacol; 2021 Dec; 101(Pt A):108280. PubMed ID: 34710845
[TBL] [Abstract][Full Text] [Related]
8. The Phagosome-Lysosome Fusion Is the Target of a Purified
Cortés HD; Gómez FA; Marshall SH
Antibiotics (Basel); 2021 Jul; 10(7):. PubMed ID: 34356768
[No Abstract] [Full Text] [Related]
9. Coinfection of porcine deltacoronavirus and porcine epidemic diarrhea virus increases disease severity, cell trophism and earlier upregulation of IFN-α and IL12.
Saeng-Chuto K; Madapong A; Kaeoket K; Piñeyro PE; Tantituvanont A; Nilubol D
Sci Rep; 2021 Feb; 11(1):3040. PubMed ID: 33542409
[TBL] [Abstract][Full Text] [Related]
10. Differential gene modulation of pattern-recognition receptor TLR and RIG-I-like and downstream mediators on intestinal mucosa of pigs infected with PEDV non S-INDEL and PEDV S-INDEL strains.
Temeeyasen G; Sinha A; Gimenez-Lirola LG; Zhang JQ; Piñeyro PE
Virology; 2018 Apr; 517():188-198. PubMed ID: 29249266
[TBL] [Abstract][Full Text] [Related]
11. Intranasal and oral vaccination with protein-based antigens: advantages, challenges and formulation strategies.
Wang S; Liu H; Zhang X; Qian F
Protein Cell; 2015 Jul; 6(7):480-503. PubMed ID: 25944045
[TBL] [Abstract][Full Text] [Related]
12. Innate endogenous adjuvants prime to desirable immune responses via mucosal routes.
Wang X; Meng D
Protein Cell; 2015 Mar; 6(3):170-84. PubMed ID: 25503634
[TBL] [Abstract][Full Text] [Related]
13. Membrane-bound IL-12 and IL-23 serve as potent mucosal adjuvants when co-presented on whole inactivated influenza vaccines.
Khan T; Heffron CL; High KP; Roberts PC
Virol J; 2014 May; 11():78. PubMed ID: 24884849
[TBL] [Abstract][Full Text] [Related]
14. Mucosal co-immunization with AIM2 enhances protective SIgA response and increases prophylactic efficacy of chitosan-DNA vaccine against coxsackievirus B3-induced myocarditis.
Chai D; Yue Y; Xu W; Dong C; Xiong S
Hum Vaccin Immunother; 2014; 10(5):1284-94. PubMed ID: 24614684
[TBL] [Abstract][Full Text] [Related]
15. Enhancement of adaptive immunity to Neisseria gonorrhoeae by local intravaginal administration of microencapsulated interleukin 12.
Liu Y; Egilmez NK; Russell MW
J Infect Dis; 2013 Dec; 208(11):1821-9. PubMed ID: 24048962
[TBL] [Abstract][Full Text] [Related]
16. Oral-nasopharyngeal dendritic cells mediate T cell-independent IgA class switching on B-1 B cells.
Kataoka K; Fujihashi K; Terao Y; Gilbert RS; Sekine S; Kobayashi R; Fukuyama Y; Kawabata S; Fujihashi K
PLoS One; 2011; 6(9):e25396. PubMed ID: 21980444
[TBL] [Abstract][Full Text] [Related]
17. Cytokines: the future of intranasal vaccine adjuvants.
Thompson AL; Staats HF
Clin Dev Immunol; 2011; 2011():289597. PubMed ID: 21826181
[TBL] [Abstract][Full Text] [Related]
18. Contributions of edema factor and protective antigen to the induction of protective immunity by Bacillus anthracis edema toxin as an intranasal adjuvant.
Duverger A; Carré JM; Jee J; Leppla SH; Cormet-Boyaka E; Tang WJ; Tomé D; Boyaka PN
J Immunol; 2010 Nov; 185(10):5943-52. PubMed ID: 20952678
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-1 family cytokines as mucosal vaccine adjuvants for induction of protective immunity against influenza virus.
Kayamuro H; Yoshioka Y; Abe Y; Arita S; Katayama K; Nomura T; Yoshikawa T; Kubota-Koketsu R; Ikuta K; Okamoto S; Mori Y; Kunisawa J; Kiyono H; Itoh N; Nagano K; Kamada H; Tsutsumi Y; Tsunoda S
J Virol; 2010 Dec; 84(24):12703-12. PubMed ID: 20881038
[TBL] [Abstract][Full Text] [Related]
20. Dendritic cell-targeting DNA-based mucosal adjuvants for the development of mucosal vaccines.
Kataoka K; Fujihashi K
Expert Rev Vaccines; 2009 Sep; 8(9):1183-93. PubMed ID: 19722892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
